Abcellera Biologics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
AbCellera Biologics Inc. has announced its 2026 Annual Meeting of Shareholders will be held virtually on June 11, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.
NASDAQ
AbCellera Biologics Inc. will hold its annual meeting of stockholders on June 12, 2025, to elect directors, ratify the appointment of KPMG LLP as the independent auditor, and conduct an advisory vote on executive compensation.
NASDAQ
AbCellera Biologics Inc. will hold its 2025 Annual Meeting of Shareholders virtually on June 12, 2025, to elect directors, ratify the appointment of KPMG LLP, and conduct a non-binding advisory vote on executive compensation.
NASDAQ
AbCellera Biologics Inc. will hold its annual meeting of stockholders on June 13, 2024, to elect directors, ratify the appointment of KPMG LLP, and approve executive compensation.
NASDAQ
AbCellera Biologics will hold its 2024 Annual Meeting of Shareholders virtually on June 13, 2024, to vote on director elections, auditor ratification, and executive compensation.